Source: Eur Respir J, 58 (3) 2003492; 10.1183/13993003.03492-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Jan Heyckendorf, Sebastian Marwitz, Maja Reimann, Korkut Avsar, Andrew R. DiNardo, Gunar Günther, Michael Hoelscher, Elmira Ibraim, Barbara Kalsdorf, Stefan H.E. Kaufmann, Irina Kontsevaya, Frank van Leth, Anna M. Mandalakas, Florian P. Maurer, Marius Müller, Dörte Nitschkowski, Ioana D. Olaru, Cristina Popa, Andrea Rachow, Thierry Rolling, Jan Rybniker, Helmut J.F. Salzer, Patricia Sanchez-Carballo, Maren Schuhmann, Dagmar Schaub, Victor Spinu, Isabelle Suárez, Elena Terhalle, Markus Unnewehr, January Weiner, Torsten Goldmann, Christoph Lange. Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. Eur Respir J, 58 (3) 2003492; 10.1183/13993003.03492-2020

Member's Comments

No comment yet.

Related content which might interest you: Effect of long-term corticosteroid treatment on microRNA and gene-expression profiles in COPD Source: Eur Respir J, 53 (4) 1801202; 10.1183/13993003.01202-2018 Year: 2019 Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment Source: Eur Respir J 2006; 28: Suppl. 50, 589s Year: 2006 Predicting outcomes and drug resistance with new standardised treatment Source: Eur Respir J 2011; 37: 974 Year: 2011 Clustering analysis for omalizumab responder patient profiles identification. Fenoma study Source: International Congress 2018 – Asthma management Year: 2018 Late Breaking Abstract - Transcriptomic signature for precise prediction of systemic drug reaction during 3HP treatment for latent tuberculosis infection Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Effect of primary cilium-associated genes expression on the survival of mesothelioma patients: In silico investigation of TCGA data. Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 Response to treatment assessment in patients with PAH by MRI based computational modelling Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Prediction of one or two years’ exacerbation free time in primary care COPD patients, a validated prediction nomogram Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017 Design and assessment of an automated prediction model for 30-day re-hospitalization after a COPD exacerbation using genetic algorithms Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Classification of antituberculosis drugs: a new proposal based on the most recent evidence Source: Eur Respir J 2015; 46: 887-893 Year: 2015 Clustering approach and effects of inhaled therapy on breath-fingerprint of newly diagnosed COPD patients: an e-nose based study Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 Can genomic signatures predict response to systemic therapy? Source: Annual Congress 2013 –Biological signatures in thoracic oncology Year: 2013 Investigation for candidate genes of glucocorticoid resistance by genome-wide gene expression profiling in animal model of asthma Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 The comparative analysis of treatment effectiveness in children and adolescents with MDR TB with anti-TB drugs of the first and second lines Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 MiRNA profiling and target validation in a murine asthma model Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 Results of traditional and new regimens of MDR/XDR TB treatment: cohort analysis Source: International Congress 2019 – Drug-resistant tuberculosis Year: 2019 Evaluation of prophylactic observations efficacy and the quality of TB treatment using a math model for primarily revealed patients Source: Eur Respir J 2004; 24: Suppl. 48, 722s Year: 2004 Serum microRNA signatures identified in a genome-wide profiling predict the mortality of patients with sepsis Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011